This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,779.47 firm fixed-price delivery order is for the supply of NAMZARIC 28 MG-10 MG CAPSULE 30S, a medication used to treat Alzheimer's disease.
The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities across multiple therapeutic areas, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.
The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for fulfilling the delivery order, which has a completion date of December 10, 2024. This contract award demonstrates the company's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Generated 3/16/25, 12:43 AM